1
|
Sapkal A, Kamble S. Greener and Environmentally Benign Methodology for the Synthesis of Pyrazole Derivatives. ChemistrySelect 2020. [DOI: 10.1002/slct.202003008] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- Aboli Sapkal
- Department of Chemistry Yashavantrao Chavan Institute of Science (Autonomous) Satara Maharashtra India
| | - Santosh Kamble
- Department of Chemistry Yashavantrao Chavan Institute of Science (Autonomous) Satara Maharashtra India
| |
Collapse
|
2
|
Gambouz K, Driowya M, Loubidi M, Tber Z, Allouchi H, El Kazzouli S, Akssira M, Guillaumet G. Unusual rearrangement of imidazo[1,5- a]imidazoles and imidazo[1,2- b]pyrazoles into imidazo[1,5- a]pyrimidines and pyrazolo[1,5- a]pyrimidines. RSC Adv 2019; 9:29051-29055. [PMID: 35528450 PMCID: PMC9071803 DOI: 10.1039/c9ra04609g] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2019] [Accepted: 09/10/2019] [Indexed: 01/19/2023] Open
Abstract
A multicomponent reaction giving easy and cheap access to a variety of bicyclic 5,5-fused hetero-rings has been developed.
Collapse
Affiliation(s)
- Khadija Gambouz
- Laboratoire de Chimie Physique et Chimie Bioorganique
- URAC 22 FSTM
- Université Hassan II – Casablanca
- Morocco
- Euromed Research Center
| | - Mohsine Driowya
- Institut de Chimie Organique et Analytique
- Université d’Orléans
- UMR CNRS 7311
- 45067 Orléans Cedex 2
- France
| | - Mohammed Loubidi
- Laboratoire de Chimie Physique et Chimie Bioorganique
- URAC 22 FSTM
- Université Hassan II – Casablanca
- Morocco
- Institut de Chimie Organique et Analytique
| | - Zahira Tber
- Laboratoire de Chimie Physique et Chimie Bioorganique
- URAC 22 FSTM
- Université Hassan II – Casablanca
- Morocco
- Institut de Chimie Organique et Analytique
| | - Hassan Allouchi
- Laboratoire de Chimie Physique
- équipe EA 7502 SIMBA
- Faculté de Pharmacie
- Université de Tours
- 37200 Tours
| | - Saïd El Kazzouli
- Euromed Research Center
- Euromed Faculty of Enginnering
- Euromed University of Fes (UEMF)
- 30000 Fès
- Morocco
| | - Mohamed Akssira
- Laboratoire de Chimie Physique et Chimie Bioorganique
- URAC 22 FSTM
- Université Hassan II – Casablanca
- Morocco
| | - Gérald Guillaumet
- Institut de Chimie Organique et Analytique
- Université d’Orléans
- UMR CNRS 7311
- 45067 Orléans Cedex 2
- France
| |
Collapse
|
3
|
Sanna M, Sicilia G, Alazzo A, Singh N, Musumeci F, Schenone S, Spriggs KA, Burley JC, Garnett MC, Taresco V, Alexander C. Water Solubility Enhancement of Pyrazolo[3,4- d]pyrimidine Derivatives via Miniaturized Polymer-Drug Microarrays. ACS Med Chem Lett 2018. [PMID: 29541359 DOI: 10.1021/acsmedchemlett.7b00456] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
A miniaturized assay was optimized to evaluate the enhanced apparent water solubility of pyrazolo[3,4-d]pyrimidine derivatives used extensively as anticancer drug scaffolds. The applied amount of drugs used in the reported strategy ranged from 5 to 10 μg per formulation which were dispensed by an inkjet 2D printer directly into a 96-well plate. The selected polymer/drug formulations with high water solubility demonstrated improved cytotoxicity against a human lung adenocarcinoma cancer cell line (A549) compared to the free drugs. We attribute the enhanced efficacy to the improved apparent-solubility of the drug molecules achieved via this methodology. This novel miniaturized method showed promising results in terms of water solubility improvement of the highly hydrophobic pyrazolo[3,4-d]pyrimidine derivatives, requiring only a few micrograms of each drug per tested polymeric formulation. In addition, the reported experimental evidence may facilitate identification of suitable polymers for combination with drug, leading to investigations on biological properties or mechanisms of action in a single formulation.
Collapse
Affiliation(s)
- Monica Sanna
- Dipartimento di Farmacia, Università degli Studi di Genova, Viale Benedetto XV 3, 16132 Genova, Italy
| | - Giovanna Sicilia
- School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, U.K
| | - Ali Alazzo
- School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, U.K
| | - Nishant Singh
- School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, U.K
| | - Francesca Musumeci
- Dipartimento di Farmacia, Università degli Studi di Genova, Viale Benedetto XV 3, 16132 Genova, Italy
| | - Silvia Schenone
- Dipartimento di Farmacia, Università degli Studi di Genova, Viale Benedetto XV 3, 16132 Genova, Italy
| | - Keith A. Spriggs
- School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, U.K
| | - Jonathan C. Burley
- School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, U.K
| | - Martin C. Garnett
- School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, U.K
| | - Vincenzo Taresco
- School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, U.K
| | - Cameron Alexander
- School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, U.K
| |
Collapse
|
4
|
Ebrahimpour Z, Shiri A, Bakavoli M, Seyedi SM, Bahreini M, Oroojalian F. Microwave-assisted synthesis and antibacterial evaluation of new derivatives of 1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one. HETEROCYCL COMMUN 2016. [DOI: 10.1515/hc-2015-0145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
AbstractSynthesis of new 1,2-dihydro-3H-pyrazolo[3,4-d] pyrimidin-3-ones4–6starting with ethyl 4-hydroxy-2-methylthio-pyrimidine-5-carboxylate (1) under classical heating and microwave-induced conditions is reported. The antibacterial activities of the synthesized compounds were evaluated using chloramphenicol and streptomycin as reference drugs.
Collapse
Affiliation(s)
- Zahra Ebrahimpour
- 1Faculty of Science, Department of Chemistry, Ferdowsi University of Mashhad, 91775-1436 Mashhad, Iran (Islamic Republic of)
| | - Ali Shiri
- 1Faculty of Science, Department of Chemistry, Ferdowsi University of Mashhad, 91775-1436 Mashhad, Iran (Islamic Republic of)
| | - Mehdi Bakavoli
- 1Faculty of Science, Department of Chemistry, Ferdowsi University of Mashhad, 91775-1436 Mashhad, Iran (Islamic Republic of)
| | - Seyed Mohammad Seyedi
- 1Faculty of Science, Department of Chemistry, Ferdowsi University of Mashhad, 91775-1436 Mashhad, Iran (Islamic Republic of)
| | - Masoumeh Bahreini
- 2Faculty of Science, Department of Biology, Ferdowsi University of Mashhad, Mashhad, Iran (Islamic Republic of)
| | - Fatemeh Oroojalian
- 3Faculty of New Sciences and Technologies, Department of Life Science Engineering, University of Tehran, 14395-1561 Tehran, Iran (Islamic Republic of)
| |
Collapse
|
5
|
Zhang W, DeRyckere D, Hunter D, Liu J, Stashko M, Minson KA, Cummings CT, Lee M, Glaros TG, Newton DL, Sather S, Zhang D, Kireev D, Janzen W, Earp HS, Graham DK, Frye SV, Wang X. UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor. J Med Chem 2014; 57:7031-41. [PMID: 25068800 PMCID: PMC4148167 DOI: 10.1021/jm500749d] [Citation(s) in RCA: 111] [Impact Index Per Article: 11.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2014] [Indexed: 12/14/2022]
Abstract
We previously reported a potent small molecule Mer tyrosine kinase inhibitor UNC1062. However, its poor PK properties prevented further assessment in vivo. We report here the sequential modification of UNC1062 to address DMPK properties and yield a new potent and highly orally bioavailable Mer inhibitor, 11, capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrated by pharmaco-dynamic (PD) studies examining phospho-Mer in leukemic blasts from mouse bone marrow. Kinome profiling versus more than 300 kinases in vitro and cellular selectivity assessments demonstrate that 11 has similar subnanomolar activity against Flt3, an additional important target in acute myelogenous leukemia (AML), with pharmacologically useful selectivity versus other kinases examined.
Collapse
Affiliation(s)
- Weihe Zhang
- Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Department of Pharmacology,
School of Medicine, and Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| | - Deborah DeRyckere
- Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States
| | - Debra Hunter
- Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Department of Pharmacology,
School of Medicine, and Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| | - Jing Liu
- Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Department of Pharmacology,
School of Medicine, and Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| | - Michael
A. Stashko
- Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Department of Pharmacology,
School of Medicine, and Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| | - Katherine A. Minson
- Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States
| | - Christopher T. Cummings
- Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States
| | - Minjung Lee
- Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States
| | - Trevor G. Glaros
- Biological
Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for
Cancer Research, Frederick, Maryland 21702, United States
| | - Dianne L. Newton
- Biological
Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for
Cancer Research, Frederick, Maryland 21702, United States
| | - Susan Sather
- Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States
| | - Dehui Zhang
- Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Department of Pharmacology,
School of Medicine, and Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| | - Dmitri Kireev
- Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Department of Pharmacology,
School of Medicine, and Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| | - William
P. Janzen
- Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Department of Pharmacology,
School of Medicine, and Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| | - H. Shelton Earp
- Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Department of Pharmacology,
School of Medicine, and Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| | - Douglas K. Graham
- Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States
| | - Stephen V. Frye
- Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Department of Pharmacology,
School of Medicine, and Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| | - Xiaodong Wang
- Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Department of Pharmacology,
School of Medicine, and Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
| |
Collapse
|
6
|
Thummar BB, Tarpada UP, Raval DK. Study on One-pot Biginelli-like Synthesis of Pyrazolo[3,4-d]pyrimidines in Bronsted Acidic Ionic Liquid Under Sonication and its Mechanism. J Heterocycl Chem 2014. [DOI: 10.1002/jhet.1870] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Bhautik B. Thummar
- Department of Chemistry; Sardar Patel University; Vallabh Vidyanagar 388120 Gujarat India
| | - Umesh P. Tarpada
- Department of Chemistry; Sardar Patel University; Vallabh Vidyanagar 388120 Gujarat India
| | - Dipak K. Raval
- Department of Chemistry; Sardar Patel University; Vallabh Vidyanagar 388120 Gujarat India
| |
Collapse
|
7
|
Liu J, Zhang W, Stashko MA, DeRyckere D, Cummings CT, Hunter D, Yang C, Jayakody CN, Cheng N, Simpson C, Norris-Drouin J, Sather S, Kireev D, Janzen WP, Earp HS, Graham DK, Frye SV, Wang X. UNC1062, a new and potent Mer inhibitor. Eur J Med Chem 2013; 65:83-93. [PMID: 23693152 PMCID: PMC3720808 DOI: 10.1016/j.ejmech.2013.03.035] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2013] [Revised: 03/11/2013] [Accepted: 03/21/2013] [Indexed: 12/01/2022]
Abstract
Abnormal activation of Mer kinase has been implicated in the oncogenesis of many human cancers including acute lymphoblastic and myeloid leukemia, non-small cell lung cancer, and glioblastoma. We have discovered a new family of small molecule Mer inhibitors, pyrazolopyrimidine sulfonamides, that potently inhibit the kinase activity of Mer. Importantly, these compounds do not demonstrate significant hERG activity in the PatchXpress assay. Through structure-activity relationship studies, 35 (UNC1062) was identified as a potent (IC50 = 1.1 nM) and selective Mer inhibitor. When applied to live tumor cells, UNC1062 inhibited Mer phosphorylation and colony formation in soft agar. Given the potential of Mer as a therapeutic target, UNC1062 is a promising candidate for further drug development.
Collapse
Affiliation(s)
- Jing Liu
- Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA
| | - Weihe Zhang
- Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA
| | - Michael A Stashko
- Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA
| | - Deborah DeRyckere
- Department of Pediatrics, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, USA
| | - Christopher T. Cummings
- Department of Pediatrics, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, USA
| | - Debra Hunter
- Lineberger Comprehensive Cancer Center, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Chao Yang
- Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA
| | - Chatura N. Jayakody
- Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA
| | - Nancy Cheng
- Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA
| | - Catherine Simpson
- Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA
| | - Jacqueline Norris-Drouin
- Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA
| | - Susan Sather
- Department of Pediatrics, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, USA
| | - Dmitri Kireev
- Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA
| | - William P. Janzen
- Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA
- Lineberger Comprehensive Cancer Center, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - H Shelton Earp
- Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
- Lineberger Comprehensive Cancer Center, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Douglas K. Graham
- Department of Pediatrics, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, USA
| | - Stephen V. Frye
- Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA
- Lineberger Comprehensive Cancer Center, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Xiaodong Wang
- Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA
| |
Collapse
|
8
|
Liu J, Yang C, Simpson C, DeRyckere D, Van Deusen A, Miley MJ, Kireev D, Norris-Drouin J, Sather S, Hunter D, Korboukh VK, Patel HS, Janzen WP, Machius M, Johnson GL, Earp HS, Graham DK, Frye SV, Wang X. Discovery of Novel Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia. ACS Med Chem Lett 2012; 3:129-134. [PMID: 22662287 DOI: 10.1021/ml200239k] [Citation(s) in RCA: 61] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Abstract
Ectopic Mer expression promotes pro-survival signaling and contributes to leukemogenesis and chemoresistance in childhood acute lymphoblastic leukemia (ALL). Consequently, Mer kinase inhibitors may promote leukemic cell death and further act as chemosensitizers increasing efficacy and reducing toxicities of current ALL regimens. We have applied a structure-based design approach to discover novel small molecule Mer kinase inhibitors. Several pyrazolopyrimidine derivatives effectively inhibit Mer kinase activity at sub-nanomolar concentrations. Furthermore, the lead compound shows a promising selectivity profile against a panel of 72 kinases and has excellent pharmacokinetic properties. We also describe the crystal structure of the complex between the lead compound and Mer, opening new opportunities for further optimization and new template design.
Collapse
Affiliation(s)
| | | | | | - Deborah DeRyckere
- Department of Pediatrics, School
of Medicine, University of Colorado Denver, Aurora, Colorado 80045, United States
| | | | | | | | | | - Susan Sather
- Department of Pediatrics, School
of Medicine, University of Colorado Denver, Aurora, Colorado 80045, United States
| | | | | | | | | | | | | | | | - Douglas K. Graham
- Department of Pediatrics, School
of Medicine, University of Colorado Denver, Aurora, Colorado 80045, United States
| | | | | |
Collapse
|
9
|
|